Company Profiles

driven by the PitchBook Platform

AGADA Biosciences

Description

Provide of orphan drug development services. The company provide centralized preclinical drug efficacy testing and phenotyping services for neuromuscular disorders, with a specific expertise in murine models of duchenne muscular dystrophy.

2013

Founded

PRIVATE

Status

1-10

Employees

Accelerator/Inc

Latest Deal Type

$26.3k

Latest Deal Amount

$26.3k

Total Amount Raised

Description

Provide of orphan drug development services. The company provide centralized preclinical drug efficacy testing and phenotyping services for neuromuscular disorders, with a specific expertise in murine models of duchenne muscular dystrophy.

Website:

www.agadabio.com

Ownership Status

Privately held (backing)

Financing Status

Accelerator/Incubator Backed

Primary Industry

Other Healthcare Technology Systems

Other Industries

Other Pharmaceuticals and Biotechnology
Drug Discovery

Primary Office

1344 Summer Street Suite 312 Halifax, Nova Scotia B3H 0A8Canada +1 (902) 442-4011
Request a free trial to the PitchBook Platform
You're viewing a free company profile from the PitchBook Platform. To explore AGADA Biosciences's full profile, request a free trial.

AGADA Biosciences Valuation and Funding

Request access
Deal TypeDateAmountRaised to DatePost-ValStatusStage

AGADA Biosciences Investors (2)

Request access
Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
Seat
Contact
Info
Global Business Accelerator ProgramOther000 0000000 0000
InnovacorpVenture CapitalMinority000 0000000 0000
Global Business Accelerator Program Other
Innovacorp Venture Capital

AGADA Biosciences Executive Team (2)

NameTitleBoard
Seat
Contact
Info
Kanneboyina Nagaraju Ph.DCo-Founder & President
Eric Hoffman Ph.DCo-Founder & Vice President
Kanneboyina Nagaraju Ph.D Co-Founder & President
Eric Hoffman Ph.D Co-Founder & Vice President
Request full access to PitchBook